About Bioventus, Inc. 
Bioventus, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 44 Schemes (15.67%)
Foreign Institutions
Held by 60 Foreign Institutions (4.73%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
148 Million
(Quarterly Results - Jun 2025)
Net Profit:
9 Million
Pharmaceuticals & Biotechnology
USD 596 Million (Micro Cap)
345.00
NA
0.00%
1.94
5.08%
3.70






